-
FDA Approves Plegridy as Intramuscular Injection for Relapsing MS
The direct-into-muscle injection form Plegridy was found in a trial to cause fewer injection site reactions than its subcutaneous form. Click here to read the full story.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.